| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/09/1989 | EP0144408B1 Dna sequence |
| 08/09/1989 | CN1034578A Recombinant dna expression vectors and dna compounds that encode isopenicillin n synthetase from aspergillus nidulans |
| 08/08/1989 | US4855406 Oncogene-related peptides |
| 08/08/1989 | US4855238 Recombinant gamma interferons having enhanced stability and methods therefor |
| 08/08/1989 | US4855237 Double-stranded DNA having sequences complementary to a single-stranded DNA and derived from a bean golden mosaic virus |
| 08/08/1989 | US4855235 Monoclonal antibodies to human leukocyte antigens |
| 08/08/1989 | US4855231 Regulatory region for heterologous gene expression in yeast |
| 08/08/1989 | US4855224 Molecularly cloned diagnostic product and method of use |
| 08/03/1989 | DE3802040A1 System for the positive selection of recombinant DNA molecules |
| 08/02/1989 | EP0326423A2 Vectors, compounds and methods for expression of a hum adenocarcinoma antigen |
| 08/02/1989 | EP0326419A2 Vaccines for the protection of animals against hypodermosis |
| 08/02/1989 | EP0326148A1 Human monoclonal antibody specific for Pseudomonas aeruginosa and hybrid cell lines |
| 08/02/1989 | EP0326127A2 Infectious bovine rhinotracheitis virus insertion mutants, vaccins containing same, and methods for the production and use of same |
| 08/02/1989 | EP0326120A2 Human IFN-beta2/IL-6, its purification and uses |
| 08/02/1989 | EP0326046A2 Production of human epidermal growth factor |
| 08/02/1989 | EP0326013A2 Novel proteins derived from human alpha2-plasmin inhibitor or proteins similar thereto |
| 08/02/1989 | EP0325849A2 Retinoic acid receptor composition and method for identifying ligands |
| 08/02/1989 | EP0325773A1 A gene coding for human 5-lipoxygenase polypeptide |
| 08/02/1989 | EP0325768A2 Non-reverting rna viruses |
| 08/02/1989 | EP0325639A1 Fibrin-binding compound and method |
| 08/02/1989 | CN1034391A Method for producing the afl ii restriction endonuclease and methylase |
| 08/02/1989 | CN1034298A The process for regeneration and transformation of cotton |
| 08/01/1989 | US4853333 Production of rotavirus in yeast |
| 08/01/1989 | US4853332 Encodes an interleukin or interferon; elimination of sites for intermolecular crosslinking or incorrect intramolicular disulfide bridging |
| 08/01/1989 | US4853331 Cloning and expression of Bacillus thuringiensis toxin gene toxic to beetles of the order Coleoptera |
| 08/01/1989 | US4853330 Human tissue plasminogen activator |
| 08/01/1989 | US4853220 Protein isolated from blood, process for preparing said protein, aantibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies |
| 08/01/1989 | US4853219 Angiogenesis inhibitors |
| 08/01/1989 | CA1258029A1 Assay for nucleic acid sequences, particularly genetic lesions |
| 07/27/1989 | WO1989006798A1 Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore |
| 07/27/1989 | WO1989006704A1 Oligonucleotide probes for detection of periodontal pathogens |
| 07/27/1989 | WO1989006703A1 Diagnosis of retinoblastoma |
| 07/27/1989 | WO1989006702A1 Selective inhibition of gene expression by photoactivatable oligonucleotides |
| 07/27/1989 | WO1989006700A1 Amplification and detection of nucleic acid sequences |
| 07/27/1989 | WO1989006699A1 Dna probe specific for hemolytic listeria |
| 07/27/1989 | WO1989006695A1 Cleaved dimers of mullerian inhibiting substance-like polypeptides |
| 07/27/1989 | WO1989006694A1 Process for selection of proteinaceous substances which mimic growth-inducing molecules |
| 07/27/1989 | WO1989006692A1 Method of treating tumor cells by inhibiting growth factor receptor function |
| 07/27/1989 | WO1989006691A2 Purified thermostable enzyme |
| 07/27/1989 | WO1989006690A1 Cloned genes encoding ig-cd4 fusion proteins and the use thereof |
| 07/27/1989 | WO1989006689A1 Genetic constructs containing the alzheimer brain amyloid gene |
| 07/27/1989 | WO1989006688A2 Novel enzyme |
| 07/27/1989 | WO1989006657A1 Pulmonary surfactant protein and related polypeptide |
| 07/27/1989 | WO1989006544A1 Heteroligating antibodies and therapeutic uses thereof |
| 07/27/1989 | WO1989006543A1 Htlv-i peptide antigen and assay |
| 07/27/1989 | WO1989006485A1 Process for obtaining intact fertile arabidopsis plants from protoplasts |
| 07/27/1989 | DE3902157A1 Amphiregulin, verfahren zu dessen herstellung und pharmazeutische mittel Amphiregulin, process for its preparation and pharmaceutical compositions |
| 07/27/1989 | DE3802237A1 Regenerationsverfahren zur herstellung von intakten fertilen arabidopsis-pflanzen aus protoplasten Regeneration process for the production of intact fertile plants from protoplasts-arabidopsis |
| 07/26/1989 | EP0325489A1 Leu 23: Monoclonal antibody for monitoring leukocyte activation |
| 07/26/1989 | EP0325474A2 Receptor protein for human B cell stimulating factor-2 |
| 07/26/1989 | EP0325400A1 Novel hybrid bacillus thuringiensis gene, plasmid, and transformed pseudomonas fluorescens |
| 07/26/1989 | EP0325262A2 Cloned genes encoding IG-CD4 fusion proteins and the use thereof |
| 07/26/1989 | EP0325224A2 Methods of producing secreted receptor analogs and biologically active peptide dimers. |
| 07/26/1989 | EP0325066A1 Method for obtaining transgenic plants, intregration vector used and plants obtained |
| 07/26/1989 | EP0325032A1 Method for separating nucleic acid |
| 07/26/1989 | EP0324969A2 Method of measuring transferrin |
| 07/26/1989 | EP0324879A1 Soluble recombinant Fc-epsilon-receptor, the preparation and the use thereof |
| 07/26/1989 | EP0324789A1 Methods of regulating metabolic stability of proteins |
| 07/26/1989 | EP0221108A4 Process and nucleic acid construct for producing reagent complexes useful in determining target nucleotide sequences. |
| 07/25/1989 | US4851512 With at least three of the first five amino acids deleted |
| 07/25/1989 | US4851349 Expression vectors encoding cardionatrin and cardiodilatin |
| 07/25/1989 | US4851348 Biologically pure escherichia coli cell line which is a deoR- mutant and which is more transformation efficient with foreign plasmids than deoR+ escherichia coli cell lines, processes for obtaining these cell lines, methods of use |
| 07/25/1989 | US4851341 Forming protein-monoclonal antibody complex, isolation, dissociating |
| 07/25/1989 | US4851340 Nontoxic to moths and flies |
| 07/25/1989 | US4851332 Specific to surface antigens |
| 07/25/1989 | US4851330 Method for detection, identification and quantitation of non-viral organisms |
| 07/19/1989 | EP0324712A2 Hirudin derivative |
| 07/19/1989 | EP0324647A2 Vector for the expression of fusion proteins and protein immunogens |
| 07/19/1989 | EP0324616A2 Template-directed photoligation |
| 07/19/1989 | EP0324556A2 Method to improve mRNA translation and use thereof for production of platelet factor-4 |
| 07/19/1989 | EP0324511A2 Methods for preparing proteins of altered structure |
| 07/19/1989 | EP0324447A2 Means and process for producing a recombinant human interleukin-1 alpha polypeptide |
| 07/19/1989 | EP0324350A1 Recombinant vaccinia virus MVA |
| 07/19/1989 | EP0324274A1 Improved expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences |
| 07/19/1989 | EP0324248A2 Method for producing the FnuDI restriction endonuclease and methylase |
| 07/19/1989 | EP0324162A1 Method of producing antibodies by genetic engineering |
| 07/19/1989 | EP0324157A1 Gene fragment coding for a rabies virus glycoprotein and process for producing a rabies virus glycoprotein using the same |
| 07/19/1989 | EP0323997A1 Recombinant dna expression vectors |
| 07/19/1989 | EP0323959A1 PROTEINE PROTEASE INHIBITORS FROM $i(STREPTOMYCES) |
| 07/19/1989 | EP0166628B1 Process for the amplification of the expression of a determined gene in bacillus subtilis and strains obtained |
| 07/18/1989 | US4849509 Hybridomas |
| 07/18/1989 | US4849407 Biologically active mosaic proteins |
| 07/18/1989 | US4849359 Fish growth hormone polypeptide |
| 07/18/1989 | US4849355 Electricity |
| 07/18/1989 | US4849351 Multiple reading frame Escherichia coli expression vectors |
| 07/18/1989 | US4849350 Novel DNA, production and use thereof |
| 07/18/1989 | US4849348 Post-transcriptional heme regulated heterologous gene expression in yeast using the leg hemoglobin leader sequence |
| 07/18/1989 | US4849335 Method for detecting the mutagenicity of substances susceptible of inducing the deterioration of cellular DNA, utilizing the production of an SOS response |
| 07/18/1989 | CA1257541A1 Method for determination of hormones |
| 07/13/1989 | WO1989006286A2 Probes for and methods of diagnosis for muscular dystrophy |
| 07/13/1989 | WO1989006283A1 Novel plasmid vector with pectate lyase signal sequence |
| 07/13/1989 | WO1989006281A1 Tris-kringle plasminogen activator with novel k2 insert |
| 07/13/1989 | WO1989006279A1 Mutated subtilisin genes |
| 07/13/1989 | WO1989006277A1 Attenuated viruses |
| 07/13/1989 | WO1989006242A1 Antibodies to a4 amyloid peptide |
| 07/13/1989 | WO1989006241A1 Sorbin and peptide derivatives which increase aborption by the mucous membranes |
| 07/13/1989 | WO1989006239A1 Elastase inhibiting polypeptides and process for their preparation by genetic recombination |
| 07/13/1989 | WO1989006138A1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
| 07/13/1989 | WO1989006135A1 Treatment of type 2 diabetes mellitus |
| 07/13/1989 | WO1989003426A3 Method of and apparatus for cell poration and cell fusion using radiofrequency electrical pulses |